In the context of mutant PIK3CA, these results indicate that TP53 mutation in the endometrial epithelium promotes an endometrial phenotype that is distinct from ARID1A mutation, suggesting distinct tumor suppressive mechanisms. Here, TP53 is linked to neoplasm.